03 March 1997
Effects of the quantity of transfused blood and duration of haemodialysotherapy on potential possibility of HBV, HCV and CMV infections in chronically dialysed patients with secondary anaemia
Andrzej Steciwko, Beata Darska-Nykiel, Witold Pisarek, Robert Konarski, Beata Konarska, Andrzej JanuszewskiMed Sci Monit 1997; 3(2): CR183-189 :: ID: 500689
Abstract
The aim of the present study was to determine the relationship, if any of HBV, HCV and CMV infections in patients treated with repeated haemodialyses to the amount of transfused blood. Attention was focused on a seroconversion phenomenon in HBV and HCV positive people. The study included 53 patients (22 males, aged 26-63 years, mean 44.81 years and 31 females, aged 20-70 years, mean 46.06 years) treated with repeated haemodialyses because of end-stage renal failure. In our research we estimated the number of erythrocytes given to patients during haemodialysis sessions in their haemodialysis departments. From the study group 30 patients were qualified to enter the programme of the r-hEPO treatment (after satisfying the entry criteria i.e. exclusion of inflammatory processes, supplementation of iron and folic acid to reach the normal level, control of aluminium level). The patients started their r-hEPO treatment at different times from the beginning of haemodialysotherapy. In these 30 patients in whom the r-hEPO treatment was introduced at a later stage 75,600 ml of RBCs were transfused prior to the initiation of r-hEPO therapy. In 15 additional patients anaemia caused by renal failure and loss of blood during haemodialyses was successfully treated with the RBC transfusion. These 15 patients received 42,000 ml of RBCs (the mean amount was 2,800 ml per person). In 8 patients no transfusion was performed and 5 of those were treated with erythropoietin.
Results/Conclusions: 1.The risk of HBV and HCV infection increased with the amount of RBCs transfused in groups I and II. 2. In group III the number of HBV, HCV and CMV infections and coexisting infections did not differ from the number of infections in subgroup A of group I and subgroup E of group II. 3.The possibility of an HCV infection increased with the duration of the haemodialysotherapy in all groups. 4. The risk of coexisting infections increased with the duration of the haemodialysotherapy.
Keywords: Blood Transfusion, haemodialysotherap, HBV, HCV and CMV infections, secondary anaemia
Editorial
01 August 2022 : Editorial
Editorial: Long-Term Effects of Symptomatic and Asymptomatic SARS-CoV-2 Infection in Children and the Changing Pathogenesis of Common Childhood Viruses Driven by the COVID-19 PandemicDOI: 10.12659/MSM.937927
Med Sci Monit 2022; 28:e937927
In Press
08 Aug 2022 : Clinical Research
A 3-Year Clinical Evaluation of Endodontically Treated Posterior Teeth Restored with Resin Nanoceramic Comp...Med Sci Monit In Press; DOI: 10.12659/MSM.937331
08 Aug 2022 : Clinical Research
Hemoglobin/Red Blood Cell Distribution Width Ratio in Peripheral Blood Is Positively Associated with Progno...Med Sci Monit In Press; DOI: 10.12659/MSM.937146
05 Aug 2022 : Clinical Research
A Retrospective Study of 98 Elderly Patients with High-Risk Lateral Femoral Wall Intertrochanteric Hip Frac...Med Sci Monit In Press; DOI: 10.12659/MSM.936923
04 Aug 2022 : Clinical Research
Radiological Assessment of Prevalance and Quality of Periapical Status of Endodontic TreatmentsMed Sci Monit In Press; DOI: 10.12659/MSM.936569
Most Viewed Current Articles
30 Dec 2021 : Clinical Research
Retrospective Study of Outcomes and Hospitalization Rates of Patients in Italy with a Confirmed Diagnosis o...DOI :10.12659/MSM.935379
Med Sci Monit 2021; 27:e935379
13 Nov 2021 : Clinical Research
Acceptance of COVID-19 Vaccination and Its Associated Factors Among Cancer Patients Attending the Oncology ...DOI :10.12659/MSM.932788
Med Sci Monit 2021; 27:e932788
08 Mar 2022 : Review article
A Review of the Potential Roles of Antioxidant and Anti-Inflammatory Pharmacological Approaches for the Man...DOI :10.12659/MSM.936292
Med Sci Monit 2022; 28:e936292
01 Nov 2020 : Review article
Long-Term Respiratory and Neurological Sequelae of COVID-19DOI :10.12659/MSM.928996
Med Sci Monit 2020; 26:e928996